What the company does
Onconetix Inc. is a leading biotechnology company at the forefront of revolutionizing cancer care through innovative diagnostic and therapeutic solutions. Utilizing a proprietary technology platform, the firm emphasizes early detection and personalized treatment approaches for a range of malignancies, aiming to fulfill a vital need in oncology. With a strong and diverse pipeline, Onconetix is strategically positioned to address the rising demand for effective cancer therapies, significantly improving patient outcomes through its advanced research and development efforts in the dynamic landscape of cancer treatment.
What the weekly tape is saying
ONCO closed the latest completed week at 1.02 USD. The 4-week return is -72.7% and the 12-week return is -96.7%. Trend Signal is inactive, Market Dynamics is 0.39. Setup signature: Risk-first tape with a 12/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 45.98 USD
- Vs Trend Line
- -97.8%
- Fair Value
- 27,220 USD
- Vs Fair Value
- -100.0%
- 52W High
- 270.0 USD
- 52W Low
- 0.09 USD
- Drawdown
- -99.6%
- Range Position
- 0.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- US Healthcare
- Sector Rank
- 632 of 1038
- Sector Percentile
- 39.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.39
- 4W MD Change
- 190.3%
- Relative Strength
- -99.16
- 4W RS Change
- -1.7%
- Expectation
- Negative
- Probability
- 29.61%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.9M
- 13W Average
- 51.7M
- 52W Average
- 14.2M
- Vs 13W
- 0.0x
- Vs 52W
- 0.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 21.6%
- 52W Volatility
- 17.1%
- Upside Weeks
- 14
- Downside Weeks
- 38
- Downside Breadth
- 73.1%
- Avg Gain / Loss
- 11.7% / -15.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 1.4M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1.02 USD | -1.0% | 45.98 USD | 27,220 USD | 0.39 | -99.16 | 1.9M | Off |
| 5 Jun 2026 | 1.03 USD | -14.2% | 49.76 USD | 28,593 USD | 0.21 | -99.18 | 1.9M | Off |
| 29 May 2026 | 1.20 USD | -3.2% | 54.29 USD | 29,454 USD | -0.00 | -99.14 | 3.0M | Off |
| 22 May 2026 | 1.24 USD | -66.8% | 59.90 USD | 30,317 USD | -0.15 | -99.14 | 196.2M | Off |
| 15 May 2026 | 3.74 USD | -1.6% | 65.74 USD | 31,201 USD | -0.43 | -97.52 | 2.9M | Off |
| 8 May 2026 | 3.80 USD | -40.2% | 71.25 USD | 32,252 USD | -0.55 | -97.63 | 6.2M | Off |
| 1 May 2026 | 6.35 USD | 8.1% | 77.21 USD | 33,386 USD | -0.53 | -96.04 | 105.7M | Off |
| 24 Apr 2026 | 5.88 USD | -20.6% | 82.20 USD | 34,519 USD | -0.52 | -96.45 | 8.3M | Off |
| 17 Apr 2026 | 7.40 USD | -32.1% | 87.65 USD | 35,685 USD | -0.38 | -95.64 | 18.6M | Off |
| 10 Apr 2026 | 10.90 USD | -28.3% | 92.35 USD | 36,840 USD | -0.40 | -93.44 | 249.9M | Off |
| 2 Apr 2026 | 15.20 USD | -21.6% | 97.07 USD | 38,006 USD | -0.49 | -90.82 | 7.1M | Off |
| 27 Mar 2026 | 19.40 USD | -37.4% | 101.2 USD | 39,150 USD | -0.54 | -88.37 | 70.2M | Off |
| 20 Mar 2026 | 31.00 USD | 14.2% | 105.4 USD | 40,316 USD | -0.62 | -82.90 | 412.9K | Off |
| 13 Mar 2026 | 27.16 USD | 11.3% | 109.4 USD | 41,438 USD | -0.54 | -86.24 | 529.8K | Off |